Optical coherence contrast imaging using gold nanorods in living mice eyes

Clinical and Experimental Ophthalmology

Volumn 43, Issue 4, 2015, Pages 358-366

  de la Zerda, Adam ^a   Prabhulkar, Shradha ^c   Perez, Victor L ^c   Ruggeri, Marco ^c   Paranjape, Amit S ^c   Habte, Frezghi ^a   Gambhir, Sanjiv S ^a,b   Awdeh, Richard M ^c  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast agent; Gold nanorods; Molecular imaging; Ophthalmic imaging; Optical coherence tomography

Indexed keywords

GOLD NANOROD; NANOROD; SODIUM CHLORIDE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; GOLD; NANOTUBE;

ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORNEA; IN VIVO STUDY; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHANTOM; SENSITIVITY ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; ANATOMY; ANATOMY AND HISTOLOGY; ANIMAL; C57BL MOUSE; CHEMISTRY; IMAGING PHANTOM; OPTICAL COHERENCE TOMOGRAPHY; PROCEDURES; THREE DIMENSIONAL IMAGING;

ANATOMY, CROSS-SECTIONAL; ANIMALS; ANTERIOR CHAMBER; CONTRAST MEDIA; CORNEA; GOLD; IMAGING, THREE-DIMENSIONAL; MICE; MICE, INBRED C57BL; NANOTUBES; PHANTOMS, IMAGING; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84932195973     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12299     Document Type: Article

References (49)

1. Huang D, Swanson EA, Lin CP etal. Optical coherence tomography. Science 1991; 254: 1178-1181.
2. Drexler W, Morgner U, Kurtner FX etal. In vivo ultrahigh-resolution optical coherence tomography. Opt Lett 1999; 24: 1221-1223.
3. Jang IK, Bouma BE, Kang DH etal. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002; 39: 604-609.
4. Otis LL, Everett MJ, Sathyam US, Colston BW Jr. Optical coherence tomography: a new imaging technology for dentistry. J Am Dent Assoc 2000; 131: 511-514.
5. de la Zerda A, Kim J-W, Galanzha EI, Gambhir SS, Zharov VP. Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics. Contrast Media Mol Imaging 2011; 6: 346-369.
6. Puliafito CA, Hee MR, Lin CP etal. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995; 102: 217-229.
7. Hee MR, Puliafito CA, Duker JS etal. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105: 360-370.
8. Hirano K, Ito Y, Suzuki T, Kojima T, Kachi S, Miyake Y. Optical coherence tomography for the noninvasive evaluation of the cornea. Cornea 2001; 20: 281-289.
9. Ntziachristos V, Razansky D. Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem Rev 2010; 110: 2783-2794.
10. Keren S, Zavaleta C, Cheng Z, de la Zerda A, Gheysens O, Gambhir SS. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci U S A 2008; 105: 5844-5849.
11. de la Zerda A, Zavaleta C, Keren S etal. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008; 3: 557-562.
12. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545-580.
13. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7: 626-634.
14. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005; 23: 1418-1423.
15. Blomley MJK, Cooke JC, Unger EC, Monaghan MJ, Cosgrove DO. Microbubble contrast agents: a new era in ultrasound. BMJ 2001; 322: 1222-1225.
16. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 2006; 110: 7238-7248.
17. Mulder WJM, Strijkers GJ, Habets JW etal. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005; 19: 2008-2010.
18. Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007; 18: 17-25.
19. Yang X, Stein EW, Ashkenazi S, Wang LV. Nanoparticles for photoacoustic imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1: 360-368.
20. de la Zerda A, Kim J-W, Galanzha EI, Gambhir SS, Zharov VP. Carbon nanotube-based photoacoustic and photothermal contrast agents. Contrast Media Mol Imaging 2011; 6: 346-369.
21. Sanvicens N, Marco MP. Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol 2008; 26: 425-433.
22. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999; 99: 2293-2352.
23. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003; 110: 15-21, quiz 2-3.
24. Willmann JK, Paulmurugan R, Chen K etal. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008; 246: 508-518.
25. Link S, Mohamed MB, El-Sayed MA. Simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J Phys Chem B 1999; 103: 3073-3077.
26. Wang L, Jacques SL, Zheng L. MCML - Monte Carlo modeling of light transport in multi-layered tissues. Comput Methods Programs Biomed 1995; 47: 131-146.
27. Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, Boppart SA. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 2007; 12: 051403.
28. Chen J, Saeki F, Wiley BJ etal. Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett 2005; 5: 473-477.
29. Oldenburg A, Toublan F, Suslick K, Wei A, Boppart S. Magnetomotive contrast for in vivo optical coherence tomography. Opt Express 2005; 13: 6597-6614.
30. Wijaya A, Hamad-Schifferli K. Ligand customization and DNA functionalization of gold nanorods via round-trip phase transfer ligand exchange. Langmuir 2008; 24: 9966-9969.
31. Grabinski C, Schaeublin N, Wijaya A etal. Effect of gold nanorod surface chemistry on cellular response. ACs Nano 2011; 5: 2870-2879.
32. Ruggeri M, Wehbe H, Jiao S etal. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2007; 48: 1808-1814.
33. American National Standards Institute. American National Standard for the Safe Use of Lasers, ANSI Standard Z1361-2000. New York: ANSI, Inc, 2000.
34. de la Zerda A, Bodapati S, Teed R etal. A comparison between time domain and spectral imaging systems for imaging quantum dots in small living animals. Mol Imaging Biol 2010; 12: 500-508.
35. Villard J, Paranjape A, Victor D, Feldman M. Applications of optical coherence tomography in cardiovascular medicine, Part 2. J Nucl Cardiol 2009; 16: 620-639.
36. Welzel J. Optical coherence tomography in dermatology: a review. Skin Res Technol 2001; 7: 1-9.
37. Boppart SA, Bouma BE, Brezinski ME, Tearney GJ, Fujimoto JG. Imaging developing neural morphology using optical coherence tomography. J Neurosci Methods 1996; 70: 65-72.
38. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005; 5: 709-711.
39. Sharp PF, Manivannan A, Xu H, Forrester JV. The scanning laser ophthalmoscope - a review of its role in bioscience and medicine. Phys Med Biol 2004; 49: 1085-1096.
40. Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004; 137: 313-322.
41. Silverman RH. High-resolution ultrasound imaging of the eye - a review. Clin Experiment Ophthalmol 2009; 37: 54-67.
42. Eghtedari M, Liopo AV, Copland JA, Oraevsky AA, Motamedi M. Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett 2009; 9: 287-291.
43. Li Z, Huang P, Zhang X etal. RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol Pharm 2010; 7: 94-104.
44. Hauck TS, Ghazani AA, Chan WC. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 2008; 4: 153-159.
45. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005; 1: 325-327.
46. Yu Y-Y, Chang S-S, Lee C-L, Wang CRC. Gold nanorods: electrochemical synthesis and optical properties. J Phys Chem B 1997; 101: 6661-6664.
47. Hammer M, Roggan A, Schweitzer D, Muller G. Optical properties of ocular fundus tissues - an in vitro study using the double-integrating-sphere technique and inverse Monte Carlo simulation. Phys Med Biol 1995; 40: 963-978.
48. Oldenburg AL, Crecea V, Rinne SA, Boppart SA. Phase-resolved magnetomotive OCT for imaging nanomolar concentrations of magnetic nanoparticles in tissues. Opt Express 2008; 16: 11525-11539.
49. Paranjape AS, Kuranov R, Baranov S etal. Depth resolved photothermal OCT detection of macrophages in tissue using nanorose. Biomed Opt Express 2010; 1: 2-16.